Why the study?
Data on Brugada Syndrome prevalence in paroxysmal AF are scarce, and many antiarrhythmic drugs for AF are contraindicated in Brugada Syndrome.
Concealed Brugada Syndrome is highly prevalent (22.9%) in young to middle-aged patients with paroxysmal atrial fibrillation without structural heart disease, highlighting the importance of screening before initiating antiarrhythmic therapy.
May warrant screening for concealed Brugada syndrome in select paroxysmal AF patients; leaves open prospective validation and outcome impact.
Funding Acknowledgements Type of funding sources: None. Background Brugada Syndrome (BS) is an inherited rhythm-disorder with risk of sudden-cardiac-death defined by a specific ST-segment elevation pattern in precordial ECG-leads either spontaneous or provoked by Na-channel-blocker-drug-provocation-test with Ajmaline and/or higher-precordial-intercostal-space (HICS)-ECGs. Scarce data denote that the prevalence of atrial fibrillation (AF) is higher in BS and most of the antiarrhythmic-drugs used in AF are contraindicated in BS. Purpose Our aim was to elucidate the frequency of BS in paroxysmal-AF (PAF) patients without heart-disease and reveal possible clinical/genetic relations. Methods Adult patients with an history of PAF less than 55-years-old were prospectively and consecutively evaluated with resting and HICS-ECGs, cardiac-examination and routine Ajmaline-drug-provocation-test (if not contraindicated). After the exclusion of subjects with any cardiac-disease, anti-arrhythmic-use, bundle-branch-blocks, pre-excitations and ventricular hypertrophies; 96 subjects ([mean±SD] age, 37.3±18, [range]18-55 years) were enrolled in the study (male n [%overall]:55 [57.2%]). All ECGs were interpreted manually by two experienced cardiologists for BS and Brugada-type-ECG-patterns (BTEPs). In 32 patients SCNA5A genetic tests were done (n: 15 BS(+) 17 BS(-) patients). In BS(+) patients, electrophysiological-study (EPS) with programmed-ventricular-stimulation (PVS) was also done and compared with the EPS parameters of BS(-) PAF patients that undergone AF-catheter-ablation-strategy (n: 30). Results Overall frequency of concealed-BS was 22,9% (n: 22 [male n: 14]). No spontaneous type-1 BTEP was found with HICS-ECGs and all BS diagnosis were Ajmaline-induced. The clinical characteristics of PAF patients with and without BS and statistical findings are presented in Table-1 and Figure-1. BS(+) patients were predominantly male, younger, slimmer, significantly more suffering from situational syncopal episodes and revealing more BTEPs by baseline HICS-ECGs. The SCN5A-mutation positivity was non-significant between BS(+) and (-) PAF patients (p= 0,80). Baseline heart-rates were lower and PR-intervals, P-wave-duration and Sinus-node-recovery-times were significantly higher in BS(+) patients. Only one BS(+) PAF patient with an history of syncope developed VF with 2 extra-beats in PVS and received an ICD. Conclusions Concealed-BS is found to be highly prevalent in middle-aged-subjects and especially males with PAF without an apparent cardiac-disorder. Knowing this considerably lethal condition might protect a vulnerable sub-group of patients from the deleterious effects of antiarrhythmics and risk stratification might confer an increased risk. Non-invasive/invasive indices regarding the delayed conduction features in atrial electrophysiological characteristics of BS(+) patients and a higher vagal state might be suggested as one of the probable mechanisms underlying the higher prevalence of AF in BS.
No takes yet. Share an insight, caveat, or question.
Hunuk et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: